TABLE 3.
Delay | Sex | Mean ± SD | t test | P | |
---|---|---|---|---|---|
First noticeable sensation | Before exposure | M | 4.17±1.31 | 0.63 | 0.53 |
F | 4.00±0.96 | ||||
5 min | M | 4.28±1.33 | 1.55 | 0.13 | |
F | 3.85±0.95 | ||||
10 min | M | 4.24±1.50 | 1.20 | 0.24 | |
F | 3.88±1.04 | ||||
20 min | M | 4.24±1.09 | 1.26 | 0.21 | |
F | 3.90±1.13 | ||||
30 min | M | 4.38±1.18 | 0.90 | 0.37 | |
F | 4.10±1.34 | ||||
10 min after the end of exposure | M | 4.34±1.14 | 0.77 | 0.44 | |
F | 4.10±1.41 | ||||
Pain threshold | Before exposure | M | 22.28±13.29 | 4.61 | <0.0001 |
F | 11.50±5.60 | ||||
5 min | M | 27.28±16.94 | 4.31 | <0.0001 | |
F | 14.15±7.85 | ||||
10 min | M | 31.69±21.71 | 4.36 | <0.0001 | |
F | 15.25±8.48 | ||||
20 min | M | 28.59±18.65 | 3.33 | 0.001 | |
F | 17.03±9.96 | ||||
30 min | M | 34.83±22.96 | 4.03 | <0.0001 | |
F | 18.23±10.59 | ||||
10 min after the end of exposure | M | 34.48±26.11 | 3.62 | 0.001 | |
F | 17.40±12.36 |
Cefar Medical AB, Sweden. F Female; M Male